PT - JOURNAL ARTICLE AU - Mélia Magnen AU - Ran You AU - Arjun A. Rao AU - Ryan T. Davis AU - Lauren Rodriguez AU - Camille R. Simoneau AU - Lisiena Hysenaj AU - Kenneth H. Hu AU - The UCSF COMET Consortium AU - Christina Love AU - Prescott G. Woodruff AU - David J. Erle AU - Carolyn M. Hendrickson AU - Carolyn S. Calfee AU - Michael A. Matthay AU - Jeroen P. Roose AU - Anita Sil AU - Melanie Ott AU - Charles R. Langelier AU - Matthew F. Krummel AU - Mark R. Looney TI - Immediate myeloid depot for SARS-CoV-2 in the human lung AID - 10.1101/2022.04.28.489942 DP - 2022 Jan 01 TA - bioRxiv PG - 2022.04.28.489942 4099 - http://biorxiv.org/content/early/2022/05/11/2022.04.28.489942.short 4100 - http://biorxiv.org/content/early/2022/05/11/2022.04.28.489942.full AB - In the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, considerable focus has been placed on a model of viral entry into host epithelial populations, with a separate focus upon the responding immune system dysfunction that exacerbates or causes disease. We developed a precision-cut lung slice model to investigate very early host-viral pathogenesis and found that SARS-CoV-2 had a rapid and specific tropism for myeloid populations in the human lung. Infection of alveolar macrophages was partially dependent upon their expression of ACE2, and the infections were productive for amplifying virus, both findings which were in contrast with their neutralization of another pandemic virus, Influenza A virus (IAV). Compared to IAV, SARS-CoV-2 was extremely poor at inducing interferon-stimulated genes in infected myeloid cells, providing a window of opportunity for modest titers to amplify within these cells. Endotracheal aspirate samples from humans with the acute respiratory distress syndrome (ARDS) from COVID-19 confirmed the lung slice findings, revealing a persistent myeloid depot. In the early phase of SARS-CoV-2 infection, myeloid cells may provide a safe harbor for the virus with minimal immune stimulatory cues being generated, resulting in effective viral colonization and quenching of the immune system.Competing Interest StatementThe authors have declared no competing interest.